The traditional patent model relies on high sales volumes to recoup costs, a mechanism that directly contradicts the global need to conserve our last-resort antibiotics. This article by Umeshkumar explores the “stewardship paradox” and argues for delinkage models to align innovation with public health and sustainable antimicrobial use.